يعرض 1,941 - 1,960 نتائج من 18,609 نتيجة بحث عن 'significantly ((((((lower decrease) OR (a decrease))) OR (greater decrease))) OR (linear decrease))', وقت الاستعلام: 0.66s تنقيح النتائج
  1. 1941
  2. 1942

    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  3. 1943

    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  4. 1944

    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  5. 1945

    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  6. 1946

    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  7. 1947

    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  8. 1948

    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  9. 1949

    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF حسب Xiang Xiao (44417)

    منشور في 2024
    "…Throughout the follow-up period, we observed a significant decrease in the rate of eGFR decline in patients using SGLT2i (4.94 mL/min/1.73 m<sup>2</sup> per year reduction compared to oGLDs, 95% CI: 4.73–5.15). …"
  10. 1950

    DataSheet1_Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice.docx حسب Teresa Fontán-Baselga (20392470)

    منشور في 2024
    "…In addition, we observed a significant decrease in the number and size of astrocytes in both sexes and in the number of microglial cells in a sex-dependent manner. …"
  11. 1951
  12. 1952

    Manhattan plot for genome-wide association study (GWAS) in a European population with depression. حسب Xiaomei He (795333)

    منشور في 2025
    "…<p>A: The x-axis represents the chromosomal position, and the y-axis represents the significance on a –log10 scale. …"
  13. 1953
  14. 1954
  15. 1955
  16. 1956

    Basic physical parameters of shield residue. حسب Shoujie Wang (18326754)

    منشور في 2024
    "…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …"
  17. 1957

    Primary composition of experimental materials. حسب Shoujie Wang (18326754)

    منشور في 2024
    "…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …"
  18. 1958

    Compaction test results. حسب Shoujie Wang (18326754)

    منشور في 2024
    "…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …"
  19. 1959

    Experimental mix proportions. حسب Shoujie Wang (18326754)

    منشور في 2024
    "…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …"
  20. 1960

    CBR test results. حسب Shoujie Wang (18326754)

    منشور في 2024
    "…The results show that the UCS and CBR values enhanced significantly with the increase in curing time. However, the moisture content and pH of the stabilized soil exhibited a decreasing trend. …"